Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Metformin is currently the first‐line treatment drug for type 2 diabetes. Metformin is a well‐known activator of AMP‐activated protein kinase (AMPK). In experimental studies, metformin has been shown to exert direct vascular effects by increasing vascular endothelial growth factor expression and improving microvascular density. As stroke is the leading cause of long‐term disability and angiogenesis is implicated as an important mechanism in functional recovery, we hypothesized that chronic metformin treatment would improve post‐stroke functional recovery by enhancing functional microvascular density. For this study, C 57 BL/6 N male mice were subjected to a 60‐min middle cerebral artery occlusion, and were given 50 mg/kg/day metformin beginning 24 h post‐stroke for 3 weeks. Behavioral recovery was assessed using adhesive‐tape removal and the apomorphine‐induced turning test. The role of angiogenesis was assessed by counting vessel branch points from fluorescein‐conjugated lectin‐perfused brain sections. Importantly even if metformin treatment was initiated 24 h after injury it enhanced recovery and significantly improved stroke‐induced behavioral deficits. This recovery occurred in parallel with enhanced angiogenesis and with restoration of endogenous cerebral dopaminergic tone and revascularization of ischemic tissue. We assessed if the effects on recovery and angiogenesis were mediated by AMPK. When tested in AMPK α‐2 knockout mice, we found that metformin treatment did not have the same beneficial effects on recovery and angiogenesis, suggesting that metformin‐induced angiogenic effects are mediated by AMPK. The results from this study suggest that metformin mediates post‐stroke recovery by enhancing angiogenesis, and these effects are mediated by AMPK signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Metformin is a well-recognized AMPK activator both in vitro and in vivo (Zhou et al., 2001).”
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Plasticity during stroke recovery: from synapse to behaviour
Murphy, T. H., & Corbett, D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2735 · Cited by 1,938 · cited 2×
“…blood to the penumbra region (Rossini et al., 2003; Murphy & Corbett, 2009), differences in organization of neuronal connections in different cortical areas (Newton et al., 2006) and variability of functional appropriation by surviving brain regions (Murphy & Corbett, 2009; Fridriksson, 2010).”
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Wang, J., Gallagher, D., DeVito, L. M., Cancino, G. I., Tsui, D., He, L., Keller, G. M., Frankland, P. W., Kaplan, D. R., & Miller, F. D. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.016 · Cited by 474
Nagata, D., Mogi, M., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300643200 · Cited by 331 · cited 2×
“AMPK signaling is a critical sensor of peripheral energy balance, and may be an important determinant of blood vessel recruitment to tissues subjected to ischemic stress (Nagata et al., 2003).”
Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke
Chopp, M., Zhang, Z. G., & Jiang, Q. (2007) · Stroke · doi:10.1161/01.str.0000250235.80253.e9 · Cited by 203 · cited 5×
“Post-stroke functional recovery is thought to occur by the compensation of lost capabilities by functionally related regions in the intact hemisphere or by the restoration of structural rewiring within the ischemic region (Chopp et al., 2007; Ergul et al., 2012).”
InfluentialMetformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells
Kim, S. A., & Choi, H. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.165 · Cited by 149
Thiyagarajan, M., Fernández, J. A., Lane, S. M., Griffin, J. H., & Zlokovic, B. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3485-08.2008 · Cited by 105 · cited 1×
“Previous studies have demonstrated that functional benefits can be achieved independently of reduction in the gross infarct volume (Thiyagarajan et al., 2008).”
Cited by
Metformin: a review of its potential indications
Wang, Y.-W., He, S.-J., Feng, X., Cheng, J., Luo, Y.-T., Tian, L., & Huang, Q. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s141675 · Cited by 320
Microglia metabolism in health and disease
Borst, K., Schwabenland, M., & Prinz, M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2018.11.006 · Cited by 95
Ruddy, R. M., Adams, K. V., & Morshead, C. M. (2019) · Science Advances · doi:10.1126/sciadv.aax1912 · Cited by 82
Obesity and Cancer: An Angiogenic and Inflammatory Link
Fukumura, D., Incio, J., Shankaraiah, R. C., & Jain, R. K. (2016) · Microcirculation · doi:10.1111/micc.12270 · Cited by 69
Metadata
- Authors
- Venna, V. R., Li, J., Hammond, M. D., Mancini, N. S., & McCullough, L. D.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2014-03-21
- Volume
- 39
- Issue
- 12
- Pages
- 2129-2138
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2066924355
- Cited by
- 134
- References
- 10
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke. https://app.cochat.ai/papers/10.1111/ejn.12556
- The paper
- Venna, V. R., Li, J., Hammond, M. D., Mancini, N. S., & McCullough, L. D. (2014). Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke. European Journal of Neuroscience. https://doi.org/10.1111/ejn.12556
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.